Sign In
Australia; NSW; VIC
News release
From:
The 'flu hit Australia hard in 2017, with 249,882 confirmed cases and 1,100 deaths, but what can we expect this time around? As the government gears up to provide three million older Aussies with two new 'flu vaccines, join us to find out what we can expect this season. Hear the latest on the virus, the vaccines, who's most at risk, and how to stay safe.
The briefing will discuss the following issues:
- The latest 'flu facts and figures
- Who is most at risk?
- What's new about the 2018 'flu vaccines?
- How important is getting the 'flu shot?
- How likely are Australians to get vaccinated?
- What's stopping Australians from getting themselves and their kids vaccinated?
- What can health professionals do to help?
Speakers:
- Laureate Professor Peter Doherty is from the Department of Microbiology and Immunology at the University of Melbourne, is Patron of the Peter Doherty Institute for Infection and Immunity, is a fellow of the Australian Academy of Science, and is a past winner of the Nobel Prize in Physiology or Medicine
- Professor Robert Booy is at the University of Sydney and is the Director of the Immunisation Coalition
- Declared interest: The Immunisation Coalition receives some of its funding from industry sources, including Sanofi Pasteur and Seqirus Australia, the manufacturers of the 'flu vaccines to be provided by the Australian government. Further information on funding is available here.
- Associate Professor Julie Leask is at the Faculty of Nursing and Midwifery at the University of Sydney
Declared interest: The AusSMC receives 2.7 per cent of its annual funding from CSL Limited (owner of Seqirus Australia, manufacturer of the Fluad vaccine, one of the vaccines to be provided by the Australian government) .
---
Join the briefing:
Date: Tue 17 Apr 2018
Start Time: 10:30am AEST
Duration: Approx 45 min
Venue: Online
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
